Epidemiology


Etiology


FeatureHelicobacter pylori–induced chronic gastritisAutoimmune gastritis
DistributionMultifocal; patchy (start from antrum)Corpus; diffuse (spares antrum)
Inflammatory cellsNeutrophils, plasma cells, lymphocytesLymphocytes, macrophages
Gastrin levelNormal or ↑
Acid productionNormal or ↓
SequelaeGastric ulcerVitamin B12 deficiency/pernicious anemia
Associated malignancyAdenocarcinoma, MALT lymphomaAdenocarcinoma, carcinoid
Risk factorsLiving in resource-limited areaOther autoimmune diseases
  • Autoimmune metaplastic atrophic gastritis (AMAG)
    • Associated with major histocompatibility haplotypes HLA-B8 and HLA-DR3
  • Environmental metaplastic atrophic gastritis (EMAG)
    • Helicobacter pylori infection
      • Most important risk factor for chronic gastritis, including atrophic gastritis
      • Colonizes mainly antrum of stomach

Pathophysiology


AMAG

  • Autoimmune destruction of the parietal cells in the gastric corpus and fundus (T-cell induced autoantibodies against H+/K+ ATPase) → achlorhydria → increased release of gastrin (due to loss of negative feedback) → G cell hyperplasia → hypergastrinemia → hyperplasia of enterochromaffin-like cells → ↑ risk of carcinoid tumors.
  • Achlorhydria impairs the intestinal absorption of inorganic iron → iron deficiency anemia (early manifestation)
  • Autoantibodies against intrinsic factorvitamin B12 deficiency → pernicious anemia

EMAG

  • Colonization by H. pylori
    • Inflammation of the antrum → destruction of D cells → ↓ somatostatin → ↑ gastrin → ↑ production of gastric acids → duodenal ulcers
    • Inflammation of the gastric body → local destruction of mucosa (via cytotoxins such as ammonia) → ↓ production of mucins and atrophy of the gastric glands → hypochlorhydria → hypergastrinemia and epithelial dysplasia → epithelial metaplasia → ↑ risk of gastric cancers

Clinical features


Diagnostics


Treatment